Gracell Biotechnologies

Gracell Biotechnologies

Biotechnology, 1155 Long Is Ave, Suzhou, New York, 11717, United States, 201-500 Employees

gracellbio.com

  • LinkedIn

Who is GRACELL BIOTECHNOLOGIES

Gracell Biotechnologies Inc. is a global clinical-stage biopharmaceutical company dedicated to discovering and developing breakthrough cell therapies. Leveraging its pioneering FasTCAR an...

Read More

map
  • 1155 Long Is Ave, Suzhou, New York, 11717, United States Headquarters: 1155 Long Is Ave, Suzhou, New York, 11717, United States
  • 2017 Date Founded: 2017
  • 201-500 Employees: 201-500
  • dollar-icon Revenue: Under $1 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834

checked-icon Does something look wrong? Fix it. | View contact records from GRACELL BIOTECHNOLOGIES

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Gracell Biotechnologies

Answer: Gracell Biotechnologies's headquarters are located at 1155 Long Is Ave, Suzhou, New York, 11717, United States

Answer: Gracell Biotechnologies's official website is https://gracellbio.com

Answer: Gracell Biotechnologies's revenue is Under $1 Million

Answer: Gracell Biotechnologies's SIC: 2834

Answer: Gracell Biotechnologies has 201-500 employees

Answer: Gracell Biotechnologies is in Biotechnology

Answer: Gracell Biotechnologies contact info: Phone number: Website: https://gracellbio.com

Answer: Gracell Biotechnologies Inc. is a global clinical-stage biopharmaceutical company dedicated to discovering and developing breakthrough cell therapies. Leveraging its pioneering FasTCAR and TruUCAR technology platforms, Gracell is developing a rich clinical-stage pipeline of multiple autologous and allogeneic product candidates with the potential to overcome major industry challenges that persist with conventional CAR-T therapies, including lengthy manufacturing time, suboptimal production quality, high therapy cost and lack of effective CAR-T therapies for solid tumors.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access